However, prior to administration of CCL21 immunotherapy, determination of CCR7 expression in EWS samples may be needed, as high expression of CCL21 and CCR7 expression in tumor cells was found to have negative effect and, one out of the 24 tested EWS samples showed high CCR7 expression in tumor cells. The gene discussed is CCL21; the disease is neoplasm.